Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 964

1.

Tegaserod for the Treatment of Irritable Bowel Syndrome.

Madia VN, Messore A, Saccoliti F, Tudino V, De Leo A, De Vita D, Bortolami M, Scipione L, Pindinello I, Costi R, Di Santo R.

Antiinflamm Antiallergy Agents Med Chem. 2019 Sep 11. doi: 10.2174/1871523018666190911121306. [Epub ahead of print]

PMID:
31518227
2.

Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease.

Iannone A, Ruospo M, Palmer SC, Principi M, Barone M, Di Leo A, Strippoli GFM.

Aliment Pharmacol Ther. 2019 Sep 9. doi: 10.1111/apt.15493. [Epub ahead of print] Review.

PMID:
31502284
3.

Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification.

McCartney A, Vignoli A, Tenori L, Fornier M, Rossi L, Risi E, Luchinat C, Biganzoli L, Di Leo A.

NPJ Breast Cancer. 2019 Aug 29;5:26. doi: 10.1038/s41523-019-0123-9. eCollection 2019.

4.

Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis.

Citraro R, Iannone M, Leo A, De Caro C, Nesci V, Tallarico M, Abdalla K, Palma E, Arturi F, De Sarro G, Constanti A, Russo E.

Brain Res Bull. 2019 Aug 27;153:133-142. doi: 10.1016/j.brainresbull.2019.08.001. [Epub ahead of print]

PMID:
31470253
5.

miR-210-3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5-fluorouracil.

Pranzini E, Leo A, Rapizzi E, Ramazzotti M, Magherini F, Giovannelli L, Caselli A, Cirri P, Taddei ML, Paoli P.

Mol Carcinog. 2019 Aug 29. doi: 10.1002/mc.23107. [Epub ahead of print]

PMID:
31468617
6.

Effectiveness of different immunoadsorption columns for anti-A/B antibody depletion.

Speer C, Kälble F, Pego da Silva L, Nusshag C, Schaier M, Becker LE, Klein K, Beimler J, Sommerer C, Leo A, Süsal C, Mehrabi A, Zeier M, Morath C.

Atheroscler Suppl. 2019 Aug 17. pii: S1567-5688(19)30053-4. doi: 10.1016/j.atherosclerosissup.2019.08.030. [Epub ahead of print]

PMID:
31447215
7.

Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response.

Pantaleo MA, Tarantino G, Agostinelli C, Urbini M, Nannini M, Saponara M, Castelli C, Stacchiotti S, Fumagalli E, Gatto L, Santini D, De Leo A, Marafioti T, Akarca A, Sabattini E, Pession A, Ardizzoni A, Indio V, Astolfi A.

Oncoimmunology. 2019 Jun 4;8(9):e1617588. doi: 10.1080/2162402X.2019.1617588. eCollection 2019.

8.

Modeling poststroke epilepsy and preclinical development of drugs for poststroke epilepsy.

Leo A, De Caro C, Nesci V, Tallarico M, De Sarro G, Russo E, Citraro R.

Epilepsy Behav. 2019 Aug 16:106472. doi: 10.1016/j.yebeh.2019.106472. [Epub ahead of print] Review.

PMID:
31427267
9.

Midwives use of best available evidence in practice: An integrative review.

De Leo A, Bayes S, Geraghty S, Butt J.

J Clin Nurs. 2019 Aug 14. doi: 10.1111/jocn.15027. [Epub ahead of print]

PMID:
31410929
10.

Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice.

McCartney A, Migliaccio I, Bonechi M, Biagioni C, Romagnoli D, De Luca F, Galardi F, Risi E, De Santo I, Benelli M, Malorni L, Di Leo A.

Front Oncol. 2019 Jul 23;9:666. doi: 10.3389/fonc.2019.00666. eCollection 2019. Review.

11.

Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary.

Leo A, Caro C, Nesci V, Palma E, Tallarico M, Iannone M, Constanti A, Sarro G, Russo E, Citraro R.

Pharmacol Rep. 2019 Apr 24;71(5):833-838. doi: 10.1016/j.pharep.2019.04.017. [Epub ahead of print]

PMID:
31386986
12.

Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats.

Citraro R, Leo A, De Caro C, Nesci V, Gallo Cantafio ME, Amodio N, Mattace Raso G, Lama A, Russo R, Calignano A, Tallarico M, Russo E, De Sarro G.

Mol Neurobiol. 2019 Jul 31. doi: 10.1007/s12035-019-01712-8. [Epub ahead of print]

PMID:
31368023
13.

Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer.

Rossi L, McCartney A, Risi E, De Santo I, Migliaccio I, Malorni L, Biganzoli L, Di Leo A.

Clin Breast Cancer. 2019 Jun 11. pii: S1526-8209(19)30307-6. doi: 10.1016/j.clbc.2019.05.019. [Epub ahead of print] Review.

PMID:
31358432
14.

Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement.

Barone M, Viggiani MT, Introna A, D'errico E, Scarafino A, Iannone A, Di Leo A, Simone IL.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jul 26:1-7. doi: 10.1080/21678421.2019.1643374. [Epub ahead of print]

PMID:
31347407
15.

Phytoestrogens: Dietary Intake, Bioavailability, and Protective Mechanisms against Colorectal Neoproliferative Lesions.

Viggiani MT, Polimeno L, Di Leo A, Barone M.

Nutrients. 2019 Jul 24;11(8). pii: E1709. doi: 10.3390/nu11081709.

16.

Hospitalized Patients with Medically Unexplained Physical Symptoms: Clinical Context and Economic Costs of Healthcare Management.

Poloni N, Caselli I, Ielmini M, Mattia M, De Leo A, Di Sarno M, Isella C, Bellini A, Callegari C.

Behav Sci (Basel). 2019 Jul 19;9(7). pii: E80. doi: 10.3390/bs9070080.

17.

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.

Pizzuti L, Krasniqi E, Barchiesi G, Della Giulia M, Izzo F, Sanguineti G, Marchetti P, Mazzotta M, Giusti R, Botticelli A, Gamucci T, Natoli C, Grassadonia A, Tinari N, Iezzi L, Tomao S, Tomao F, Tonini G, Santini D, Astone A, Michelotti A, De Angelis C, Mentuccia L, Vaccaro A, Magnolfi E, Gelibter A, Magri V, Cortesi E, D'Onofrio L, Cassano A, Rossi E, Cazzaniga M, Moscetti L, Omarini C, Piacentini F, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Bria E, La Verde N, Samaritani R, Garufi C, Barni S, Mirabelli R, Sarmiento R, Veltri EM, D'Auria G, Paris I, Giotta F, Lorusso V, Cardillo F, Landucci E, Mauri M, Ficorella C, Roselli M, Adamo V, Ricciardi GRR, Russo A, Berardi R, Pistelli M, Fiorio E, Cannita K, Sini V, D'Ostilio N, Foglietta J, Greco F, Zamagni C, Garrone O, Di Cocco B, Baldini E, Livi L, Desideri I, Meattini I, Sarobba G, Del Medico P, De Tursi M, Generali D, De Maria R, Risi E, Ciliberto G, Sperduti I, Villa A, Barba M, Di Leo A, Vici P.

Int J Cancer. 2019 Jul 22. doi: 10.1002/ijc.32583. [Epub ahead of print]

PMID:
31330065
18.

Outcomes and complications following ABO-incompatible kidney transplantation performed after desensitization by semi-selective immunoadsorption - a retrospective study.

Speer C, Kälble F, Nusshag C, Pego da Silva L, Schaier M, Becker LE, Klein K, Sommerer C, Beimler J, Leo A, Waldherr R, Mehrabi A, Süsal C, Zeier M, Morath C.

Transpl Int. 2019 Jul 19. doi: 10.1111/tri.13482. [Epub ahead of print]

PMID:
31322786
19.

Vortex lattice instability at the nanoscale in a parallel magnetic field.

Grimaldi G, Leo A, Avitabile F, Martucciello N, Galluzzi A, Polichetti M, Pace S, Nigro A.

Nanotechnology. 2019 Oct 18;30(42):424001. doi: 10.1088/1361-6528/ab3314. Epub 2019 Jul 17.

PMID:
31315103
20.

Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institution.

Barchiesi G, McCartney A, Biagioni C, Siclari O, Rossi L, Pestrin M, Di Leo A, Biganzoli L.

Breast J. 2019 Jul 16. doi: 10.1111/tbj.13437. [Epub ahead of print]

PMID:
31310384
21.

Brain Hemodynamic Intermediate Phenotype Links Vitamin B12 to Cognitive Profile of Healthy and Mild Cognitive Impaired Subjects.

Cecchetti L, Lettieri G, Handjaras G, Leo A, Ricciardi E, Pietrini P, Pellegrini S; The Train the Brain Consortium .

Neural Plast. 2019 Jun 2;2019:6874805. doi: 10.1155/2019/6874805. eCollection 2019.

22.

Malnutrition, sarcopenia, and refractory ascites in end stage liver diseases: is there a way to climb back up?

Rendina M, Viggiani MT, Di Leo A, Barone M.

Dig Liver Dis. 2019 Jul 2. pii: S1590-8658(19)30639-5. doi: 10.1016/j.dld.2019.06.002. [Epub ahead of print] No abstract available.

PMID:
31278015
23.

Can the Antisecretory Factor Be Considered a New Therapy for the Short Bowel Syndrome?

Viggiani MT, Di Leo A, Barone M.

Nutr Metab Insights. 2019 May 23;12:1178638819852061. doi: 10.1177/1178638819852061. eCollection 2019.

24.

Atypical fibroxanthoma associated with differentiated-type vulvar intraepithelial neoplasia: Case report of an unusual entity.

De Leo A, Ricci C, Terzano P, Santini D, Corti B.

JAAD Case Rep. 2019 May 8;5(5):448-450. doi: 10.1016/j.jdcr.2019.03.003. eCollection 2019 May. No abstract available.

25.

Sclerosing Angiomatoid Nodular Transformation of the Adrenal Gland: A Case Report of a Novel Histopathological Entity.

Zavatta G, De Leo A, Bacci F, Mosconi C, Cosentino ER, Nanni C, Selva S, Santini D, Vicennati V, Di Dalmazi G.

J Endocr Soc. 2019 May 7;3(6):1207-1213. doi: 10.1210/js.2019-00013. eCollection 2019 Jun 1.

26.

Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma.

Barone M, Viggiani MT, Losurdo G, Principi M, Leo AD.

World J Gastroenterol. 2019 May 28;25(20):2524-2538. doi: 10.3748/wjg.v25.i20.2524.

27.

A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed.

Ceccarelli C, De Leo A, Chieco P, Zamagni C, Zamagni A, Rubino D, Taffurelli M, Santini D.

PLoS One. 2019 Jun 3;14(6):e0217937. doi: 10.1371/journal.pone.0217937. eCollection 2019.

28.

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.

Rossi L, Biagioni C, McCartney A, Migliaccio I, Curigliano G, Sanna G, Moretti E, Minisini AM, Cinieri S, Tondini C, Arpino G, Bernardo A, Martignetti A, Risi E, Pestrin M, Boni L, Benelli M, Biganzoli L, Di Leo A, Malorni L.

Breast Cancer Res. 2019 May 29;21(1):71. doi: 10.1186/s13058-019-1149-5.

29.

Common spatiotemporal processing of visual features shapes object representation.

Papale P, Betta M, Handjaras G, Malfatti G, Cecchetti L, Rampinini A, Pietrini P, Ricciardi E, Turella L, Leo A.

Sci Rep. 2019 May 20;9(1):7601. doi: 10.1038/s41598-019-43956-3.

30.

Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior.

Leo A, Citraro R, Tallarico M, Iannone M, Fedosova E, Nesci V, De Sarro G, Sarkisova K, Russo E.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Aug 30;94:109652. doi: 10.1016/j.pnpbp.2019.109652. Epub 2019 May 13.

PMID:
31095993
31.

A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer.

Robertson JFR, Jiang Z, Di Leo A, Ohno S, Pritchard KI, Ellis M, Bradbury I, Campbell C.

Breast Cancer. 2019 May 11. doi: 10.1007/s12282-019-00973-4. [Epub ahead of print]

PMID:
31079343
32.

Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT).

McCartney A, Biagioni C, Schiavon G, Bergqvist M, Mattsson K, Migliaccio I, Benelli M, Romagnoli D, Bonechi M, Boccalini G, Pestrin M, Galardi F, De Luca F, Biganzoli L, Piccart M, Gradishar WJ, Chia S, Di Leo A, Malorni L.

Eur J Cancer. 2019 Jun;114:55-66. doi: 10.1016/j.ejca.2019.04.002. Epub 2019 May 3.

PMID:
31059974
33.

RETHINKING THE ROBOTIC REHABILITATION PATHWAY FOR PEOPLE WITH AMYOTROPHIC LATERAL SCLEROSIS: A NEED FOR CLINICAL TRIALS.

Calabrò RS, Portaro S, Manuli A, Leo A, Naro A, Bramanti A.

Innov Clin Neurosci. 2019 Jan 1;16(1-2):11-12. No abstract available.

34.

Comparison of different methods for the extraction of cannabinoids from cannabis.

De Vita D, Madia VN, Tudino V, Saccoliti F, De Leo A, Messore A, Roscilli P, Botto A, Pindinello I, Santilli G, Scipione L, Costi R, Di Santo R.

Nat Prod Res. 2019 Apr 29:1-7. doi: 10.1080/14786419.2019.1601194. [Epub ahead of print]

PMID:
31035854
35.

Granular cell tumour of the breast: A rare presentation of a breast mass in an elderly female with a subsequent breast cancer diagnosis.

Al-Balas M, De Leo A, Serra M, Santini D, Taffurelli M.

SAGE Open Med Case Rep. 2019 Apr 9;7:2050313X19841154. doi: 10.1177/2050313X19841154. eCollection 2019.

36.

Fatty acid transport protein 2 reprograms neutrophils in cancer.

Veglia F, Tyurin VA, Blasi M, De Leo A, Kossenkov AV, Donthireddy L, To TKJ, Schug Z, Basu S, Wang F, Ricciotti E, DiRusso C, Murphy ME, Vonderheide RH, Lieberman PM, Mulligan C, Nam B, Hockstein N, Masters G, Guarino M, Lin C, Nefedova Y, Black P, Kagan VE, Gabrilovich DI.

Nature. 2019 May;569(7754):73-78. doi: 10.1038/s41586-019-1118-2. Epub 2019 Apr 17.

PMID:
30996346
37.

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.

Ribi K, Luo W, Colleoni M, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Di Lauro V, Gomez HL, Ruhstaller T, Abdi E, Biganzoli L, Müller B, Barbeaux A, Graas MP, Rabaglio M, Francis PA, Foukakis T, Pagani O, Graiff C, Vorobiof D, Maibach R, Di Leo A, Gelber RD, Goldhirsch A, Coates AS, Regan MM, Bernhard J; SOLE Investigators.

Br J Cancer. 2019 May;120(10):959-967. doi: 10.1038/s41416-019-0435-4. Epub 2019 Apr 10.

PMID:
30967649
38.

Visual imagery and visual perception induce similar changes in occipital slow waves of sleep.

Bernardi G, Betta M, Cataldi J, Leo A, Haba-Rubio J, Heinzer R, Cirelli C, Tononi G, Pietrini P, Ricciardi E, Siclari F.

J Neurophysiol. 2019 Jun 1;121(6):2140-2152. doi: 10.1152/jn.00085.2019. Epub 2019 Apr 3.

PMID:
30943100
39.

Functional Brain Network Topology Discriminates between Patients with Minimally Conscious State and Unresponsive Wakefulness Syndrome.

Cacciola A, Naro A, Milardi D, Bramanti A, Malatacca L, Spitaleri M, Leo A, Muscoloni A, Cannistraci CV, Bramanti P, Calabrò RS, Anastasi GP.

J Clin Med. 2019 Mar 5;8(3). pii: E306. doi: 10.3390/jcm8030306.

40.

Formant Space Reconstruction From Brain Activity in Frontal and Temporal Regions Coding for Heard Vowels.

Rampinini AC, Handjaras G, Leo A, Cecchetti L, Betta M, Marotta G, Ricciardi E, Pietrini P.

Front Hum Neurosci. 2019 Feb 8;13:32. doi: 10.3389/fnhum.2019.00032. eCollection 2019.

41.

Pinning energy and anisotropy properties of a Fe(Se, Te) iron based superconductor.

Galluzzi A, Buchkov K, Nazarova E, Tomov V, Grimaldi G, Leo A, Pace S, Polichetti M.

Nanotechnology. 2019 Jun 21;30(25):254001. doi: 10.1088/1361-6528/ab0c23. Epub 2019 Mar 4.

PMID:
30831561
42.

The Spectrum of Small Intestinal Lesions in Patients with Unexplained Iron Deficiency Anemia Detected by Video Capsule Endoscopy.

Contaldo A, Losurdo G, Albano F, Iannone A, Barone M, Ierardi E, Di Leo A, Principi M.

Medicina (Kaunas). 2019 Feb 27;55(3). pii: E59. doi: 10.3390/medicina55030059.

43.

The role of robotic gait training and tDCS in Friedrich ataxia rehabilitation: A case report.

Portaro S, Russo M, Bramanti A, Leo A, Billeri L, Manuli A, La Rosa G, Naro A, Calabrò RS.

Medicine (Baltimore). 2019 Feb;98(8):e14447. doi: 10.1097/MD.0000000000014447.

44.

Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes.

Bates JE, De Leo AN, Morris CG, Amdur RJ, Dagan R.

Head Neck. 2019 Jul;41(7):2309-2314. doi: 10.1002/hed.25695. Epub 2019 Feb 20.

PMID:
30788878
45.

Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib.

Nannini M, Tarantino G, Indio V, Ravegnini G, Astolfi A, Urbini M, De Leo A, Santini D, Ceccarelli C, Gruppioni E, Altimari A, Castellucci P, Fanti S, Di Scioscio V, Saponara M, Gatto L, Pession A, Martelli PL, Casadio R, Pantaleo MA.

Sci Rep. 2019 Feb 18;9(1):2172. doi: 10.1038/s41598-018-38028-x.

46.

Experience of nail bed injuries at a tertiary hand trauma unit: a 12-month review and cost analysis.

Yildirimer L, Brewster CT, Aziz H, Unluer Z, Jemec B, De Leo A.

J Hand Surg Eur Vol. 2019 May;44(4):419-423. doi: 10.1177/1753193419826465. Epub 2019 Feb 18.

PMID:
30776945
47.

Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial.

Loi S, Giobbie-Hurder A, Gombos A, Bachelot T, Hui R, Curigliano G, Campone M, Biganzoli L, Bonnefoi H, Jerusalem G, Bartsch R, Rabaglio-Poretti M, Kammler R, Maibach R, Smyth MJ, Di Leo A, Colleoni M, Viale G, Regan MM, André F; International Breast Cancer Study Group and the Breast International Group.

Lancet Oncol. 2019 Mar;20(3):371-382. doi: 10.1016/S1470-2045(18)30812-X. Epub 2019 Feb 11.

PMID:
30765258
48.

A suspected case of anesthesia-induced rhabdomyolysis in a child undergoing strabismus surgery.

Leo AM, McVey MJ, Iizuka M, Richards MD.

J AAPOS. 2019 Jun;23(3):167-169. doi: 10.1016/j.jaapos.2019.01.006. Epub 2019 Feb 5.

PMID:
30735783
49.

DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.

Del Re M, Cinieri S, Michelucci A, Salvadori S, Loupakis F, Schirripa M, Cremolini C, Crucitta S, Barbara C, Di Leo A, Latiano TP, Pietrantonio F, Di Donato S, Simi P, Passardi A, De Braud F, Altavilla G, Zamagni C, Bordonaro R, Butera A, Maiello E, Pinto C, Falcone A, Mazzotti V, Morganti R, Danesi R.

Pharmacogenomics J. 2019 Feb 6. doi: 10.1038/s41397-019-0077-1. [Epub ahead of print]

50.

The optimal duration of adjuvant endocrine therapy in early luminal breast cancer: A concise review.

Rossi L, McCartney A, De Santo I, Risi E, Moretti E, Malorni L, Biganzoli L, Di Leo A.

Cancer Treat Rev. 2019 Mar;74:29-34. doi: 10.1016/j.ctrv.2019.01.007. Epub 2019 Jan 25. Review.

PMID:
30708267

Supplemental Content

Support Center